Development of [89Zr]ZrDFO-amivantamab bispecific to EGFR and c-MET for PET imaging of triple-negative breast cancer
Alessandra Cavaliere, Suxia Sun, Supum Lee, Jacob Bodner, Ziqi Li, Yiyun Huang, Sheri L. Moores, Bernadette Marquez‐Nostra
Topics & Concepts
Triple-negative breast cancerEpidermal growth factor receptorBiodistributionMedicineBreast cancerCancer researchIn vivoC-MetCancerTargeted therapyLung cancerRadioligandReceptorPathologyHepatocyte growth factorBiologyInternal medicineBiotechnologyRadiopharmaceutical Chemistry and ApplicationsHER2/EGFR in Cancer ResearchLung Cancer Treatments and Mutations